| The microbial diversity following antibiotic treatment of Clostridioides difficile infection D Binyamin, O Nitzan, M Azrad, Z Hamo, O Koren, A Peretz BMC gastroenterology 21, 1-6, 2021 | 14 | 2021 |
| Characterization of the Immune Response during Infection Caused by Clostridioides difficile Z Hamo, M Azrad, O Nitzan, A Peretz Microorganisms 7 (10), 435, 2019 | 11 | 2019 |
| Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection Z Hamo, M Azrad, O Nitzan, A Sagie, L Tkhawkho, D Binyamin, A Peretz Frontiers in microbiology 8, 2532, 2017 | 11 | 2017 |
| The cytopathic effect of different toxin concentrations from different Clostridioides difficile sequence types strains in vero cells Z Hamo, M Azrad, B Fichtman, A Peretz Frontiers in Microbiology 12, 763129, 2021 | 9 | 2021 |
| Elevated serum immunoglobulin A levels in patients with Clostridium difficile infection are associated with mortality M Azrad, Z Hamo, L Tkhawkho, A Peretz Pathogens and disease 76 (6), fty066, 2018 | 8 | 2018 |
| In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile D Binyamin, O Nitzan, M Azrad, Z Hamo, O Koren, A Peretz Frontiers in Microbiology 9, 1256, 2018 | 7 | 2018 |
| IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection D Gotshal, M Azrad, Z Hamo, O Nitzan, A Peretz Pathogens 10 (5), 631, 2021 | 5 | 2021 |
| Reduced Susceptibility to Chlorhexidine among Staphylococcus aureus Isolates in Israel: Phenotypic and Genotypic Tolerance M Azrad, C Shmuel, T Leshem, Z Hamo, M Baum, A Rokney, ... Antibiotics 10 (3), 342, 2021 | 4 | 2021 |
| The diagnostic performance and accuracy of 3 molecular assays for the detection of Clostridium difficile in stool samples, compared with the Xpert® C. difficile assay M Azrad, L Tkhawkho, Z Hamo, A Peretz Journal of microbiological methods 168, 105784, 2020 | 3 | 2020 |
| The effect of different C. difficile MLST strains on viability and activity of macrophages G Saad, M Azrad, M Aias, T Leshem, Z Hamo, LA Rahmoun, A Peretz Heliyon 9 (3), 2023 | 1 | 2023 |
| Associations of motility and auto-aggregation with biofilm-formation capacity levels in Clostridioides difficile M Azrad, L Abu-Rahmoun, Z Hamo, A Peretz Microbial Pathogenesis 186, 106490, 2024 | | 2024 |
| Different bile acids have versatile effects on sporulation, toxin levels and biofilm formation of different Clostridioides difficile strains M Aias, M Azrad, G Saad, T Leshem, Z Hamo, LA Rahmoun, A Peretz Journal of Microbiological Methods 206, 106692, 2023 | | 2023 |
| IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection. Pathogens 2021, 10, 631 D Gotshal, M Azrad, Z Hamo, O Nitzan, A Peretz s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Characterization of the Immune Response in Patients Infected with Clostridioides Difficile Due to Serum Biomarkers' Level with Correlation to Clinical Characteristics and … D Gotshal, M Azrad, Z Hamo, O Nitzan, A Peretz | | 2020 |
| Microbiota diversity following antibiotic treatment of Clostridium difficile infection D Binyamin, O Nitzan, M Azrad, Z Hamo, O Koren, A Peretz | | 2020 |
| Molecular Characterization and Moxifloxacin Susceptibility of Clostridium difficile S Mizrahi, Z Hamo, M Azrad, A Peretz Antibiotics 8 (3), 118, 2019 | | 2019 |
